News
CALZF
0.735
NaN%
--
PolyNovo shareholders back all resolutions at 2026 AGM
TipRanks · 2h ago
PolyNovo posts strong FY26 growth as it advances U.S. burn approval and expands capacity
TipRanks · 7h ago
PolyNovo CFO to Exit After Eight Years Amid Strong Growth
TipRanks · 10/19 22:10
PolyNovo sets hybrid 2026 AGM with vote on pay and board
TipRanks · 09/27 23:29
PolyNovo refreshes board with new non-executive directors to drive global growth
TipRanks · 09/16 22:45
PolyNovo files updated corporate governance statement and Appendix 4G
TipRanks · 09/14 23:39
PolyNovo Targets Global Scale on Proven Wound-Care Platform
TipRanks · 09/14 23:38
Polynovo Earnings Call Highlights Strong MTX Momentum
TipRanks · 08/30 00:16
Bell Potter upgrades Polynovo (CALZF) to a Buy
TipRanks · 08/28 00:45
Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)
TipRanks · 08/27 23:40
Morgans Sticks to Their Buy Rating for Polynovo (CALZF)
TipRanks · 08/27 03:35
Macquarie Keeps Their Buy Rating on Polynovo (CALZF)
TipRanks · 08/26 05:35
PolyNovo issues FY26 results presentation with extensive risk and liability warnings
TipRanks · 08/25 22:12
PolyNovo boosts FY26 sales and cash flow as NovoSorb platform and manufacturing scale up
TipRanks · 08/25 22:12
JPMorgan Group Ceases to Be Substantial Holder in Polynovo
TipRanks · 08/23 22:37
PolyNovo to Live Stream FY26 Results as Global Wound Care Platform Expands
TipRanks · 08/17 00:23
Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF), Oneview Healthcare Chess Depository Interests repr 1 (OtherONVVF) and Polynovo (OtherCALZF)
TipRanks · 07/30 01:10
Macquarie Keeps Their Buy Rating on Polynovo (CALZF)
TipRanks · 07/27 00:05
Bell Potter downgrades Polynovo (CALZF) to a Hold
TipRanks · 07/24 00:35
JPMorgan Group Ceases to Be Substantial Holder in PolyNovo
TipRanks · 07/23 22:43
More
Webull provides a variety of real-time CALZF stock news. You can receive the latest news about Polynovo through multiple platforms. This information may help you make smarter investment decisions.
About CALZF
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.